Stockreport

Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates

Orchestra BioMed Holdings, Inc. - Ordinary Shares  (OBIO) 
PDF Secured $147.6 million in proceeds and committed capital following completion of strategic transactions and concurrent public and private equity offerings, led by $71.6 [Read more]